You have 9 free searches left this month | to do more

akst4290

Akst4290 is a drug used to treat Diabetic Retinopathy, Neovascular Age-related Macular Degeneration, Parkinson Disease, and other conditions. Akst4290 is being actively studied in 1 study and prior, has been studied in 3.

Top SponsorsTop SitesTop Investigators
Alkahest, Inc.AS Ida-Tallinna Keskhaigla / East Tallinn Central Hospital
ArtOptica Salon Okulistyczno
Astra Kliinik / Astra Team Clinic
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Completed
  • Pemphigoid, Bullous
  • Mometasone furoate
  • +2 more
  • Dresden, Germany
  • +7 more
2021-07-06
Jul 6, 2021
A
Recruiting
  • Diabetic Retinopathy
  • AKST4290
  • Placebo
  • Phoenix, Arizona
  • +16 more
2021-10-25
Oct 25, 2021
A
Completed
  • Neovascular Age-related Macular Degeneration
  • AKST4290
  • +2 more
  • Beverly Hills, California
  • +20 more
2021-10-07
Oct 7, 2021
A
Completed
  • Parkinson Disease
  • AKST4290
  • Placebo
  • Atlanta, Georgia
  • +21 more
2021-05-11
May 11, 2021